Search Results

You are looking at 31 - 40 of 48 items for :

  • "evidence-based medicine" x
  • Refine by Access: All x
Clear All
Full access

. “Evidence-based medicine should be the foundation of any oncology care model and results in high-quality care as well as cost containment. Deviation from guidelines is associated with poor patient outcomes and increased costs. Care Delivery Organizations are

Full access

pathways—Value Pathways Powered by NCCN—delivered through innovative technology and built on The US Oncology Network Level I Pathways. Anchored in clinical quality and evidence-based medicine, Value Pathways Powered by NCCN aim to align quality and value as

Full access

Holbrook E. Kohrt and Steven E. Coutre

. 46. Visani G Olivieri A Malagola M . Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine . Leuk Lymphoma 2006 ; 47 : 1091 – 1102 . 47. Reiffers J Gaspard MH Maraninchi D

Full access

Estanislao Arana, Francisco M. Kovacs, Ana Royuela, Beatriz Asenjo, Úrsula Pérez-Ramírez, Javier Zamora, and the Spanish Back Pain Research Network Task Force for the Improvement of Inter-Disciplinary Management of Spinal Metastasis

Washington MK Adsay NV . Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma . Arch Pathol Lab Med 2014 ; 138 : 636 – 642 . 27. Dea N Fisher CG . Evidence-based medicine

Full access

Jia-Wei Lv, Yu-Pei Chen, Guan-Qun Zhou, Xu Liu, Ying Guo, Yan-Ping Mao, Jun Ma, and Ying Sun

—removing unnecessary obstacles . N Engl J Med 2013 ; 369 : 1061 – 1065 . 2. Craig JC Irwig LM Stockler MR . Evidence-based medicine: useful tools for decision making . Med J Aust 2001 ; 174 : 248 – 253 . 3. Simes RJ . Publication bias: the

Full access

Kathryn P. Pennington, Renata R. Urban, and Heidi J. Gray

published findings of the LACC trial available, we have an obligation to our patients to practice evidence-based medicine and determine how to appropriately integrate the findings into our clinical practice. Concerns have been raised regarding whether these

Full access

Ronan J. Kelly

received trimodality therapy but whose postoperative surgical pathology report shows lymph node–positive disease. Many oncologists feel the need to give additional chemotherapy, but this approach is not supported by evidence-based medicine. The hope is that

Full access

Yu-Pei Chen, Ya-Qin Wang, Wen-Fei Li, Lei Chen, Cheng Xu, Tai-Xiang Lu, Ai-Hua Lin, Ji-Jin Yao, Yang-Chan Li, Ying Sun, Yan-Ping Mao, and Jun Ma

Oncol 2012 ; 13 : 163 – 171 . 41. Hayward RS Wilson MC Tunis SR . Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? The Evidence-Based Medicine Working Group . JAMA

Full access

Jeffrey S. Montgomery, David C. Miller, and Alon Z. Weizer

. 17 Madeb R Golijanin D Noyes K . Treatment of nonmuscle invading bladder cancer: do physicians in the United States practice evidence based medicine? The use and economic implications of intravesical chemotherapy after transurethral resection of

Full access

Siew Tzuh Tang, Tsang-Wu Liu, Fur-Hsing Wen, Chiun Hsu, Yi-Heng Chang, Cheng-Shyong Chang, Yung-Chuan Sung, Cheng-I Hsieh, Shou-Yi Chang, Li Ni Liu, and Ming-Chu Chiang

. Kao YH Goh CR . The practice of nondisclosure of advanced cancer diagnosis in Singapore: a continuing challenge . Singapore Med J 2013 ; 54 : 255 – 258 . 23. Kravitz RL Duan N Braslow J . Evidence-based medicine, heterogeneity of